نتایج جستجو برای: fecal occult blood test fobt

تعداد نتایج: 1458947  

2017
Diana E. Yung Sanju Vijayan Tomer Avni Sarah Douglas Uri Kopylov Anastasios Koulaouzidis

BACKGROUND Fecal occult blood testing (FOBT) has been suggested as a potential screening tool for small-bowel capsule endoscopy (CE). We conducted a meta-analysis of studies correlating FOBT and CE findings to examine the predictive value of positive FOBT for CE findings. METHODS PubMed and Embase search. Sensitivity, specificity and diagnostic odds ratios (DORs) were calculated. RESULTS Si...

2008
James E. Allison

20 THE AVAILABLE FECAL OCCULT BLOOD TESTS— THE GUAIAC TESTS (GT) In 1985, Simon published an excellent review of FOBT testing for colorectal cancer (11). He stated that the concept of occult blood detection is generally credited to Van Deen, who in 1864 used gum guaiac, as an indicator reagent. Boas was the first to demonstrate its value for the detection of bowel malignancy (12) and Greegor wa...

Journal: :Gut 2007
L Guittet V Bouvier N Mariotte J P Vallee D Arsène S Boutreux J Tichet G Launoy

BACKGROUND The guaiac faecal occult blood test (G-FOBT) is recommended as a screening test for colorectal cancer but its low sensitivity has prevented its use throughout the world. METHODS We compared the performances of the reference G-FOBT (non-rehydrated Hemoccult II test) and the immunochemical faecal occult blood test (I-FOBT) using different positivity cut-off values in an average risk ...

Journal: :CA: A Cancer Journal for Clinicians 1984

2014
Georg Zeller Julien Tap Anita Y Voigt Shinichi Sunagawa Jens Roat Kultima Paul I Costea Aurélien Amiot Jürgen Böhm Francesco Brunetti Nina Habermann Rajna Hercog Moritz Koch Alain Luciani Daniel R Mende Martin A Schneider Petra Schrotz-King Christophe Tournigand Jeanne Tran Van Nhieu Takuji Yamada Jürgen Zimmermann Vladimir Benes Matthias Kloor Cornelia M Ulrich Magnus von Knebel Doeberitz Iradj Sobhani Peer Bork

Several bacterial species have been implicated in the development of colorectal carcinoma (CRC), but CRC-associated changes of fecal microbiota and their potential for cancer screening remain to be explored. Here, we used metagenomic sequencing of fecal samples to identify taxonomic markers that distinguished CRC patients from tumor-free controls in a study population of 156 participants. Accur...

2002
Aurelien Amiot Hicham Mansour Isabelle Baumgaertner Jean-Charles Delchier Christophe Tournigand Jean-Pierre Furet Jean-Pierre Carrau Florence Canoui-Poitrine Iradj Sobhani

BACKGROUND The clinical benefit of guaiac fecal occult blood tests (FOBT) is now well established for colorectal cancer screening. Growing evidence has demonstrated that epigenetic modifications and fecal microbiota changes, also known as dysbiosis, are associated with CRC pathogenesis and might be used as surrogate markers of CRC. PATIENTS AND METHODS We performed a cross-sectional study tha...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005
Sujha Subramanian Mayur M Amonkar Timothy L Hunt

BACKGROUND The use of colonoscopy as a primary screening tool for colorectal cancer is gaining momentum owing to several studies suggesting superior effectiveness and the recent, favorable decision by Medicare to cover all routine screening colonoscopies. This study documents the use of colonoscopy versus other tests to screen for colorectal cancer. MATERIALS AND METHODS Data from the 2000 Na...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004
Sarah T Hawley Sally W Vernon Bernard Levin Beryl Vallejo

The primary objective of this study was to determine the prevalence of colorectal cancer (CRC) screening among eligible patients in a large medical practice. A secondary objective was to compare CRC screening rates obtained from medical records with physician self-reported CRC screening recommendation. We conducted a retrospective record review of 214 patients ages > or = 50 years of a large mu...

Journal: :Annals of family medicine 2010
Joshua J Fenton Joann G Elmore Diana S M Buist Robert J Reid Daniel J Tancredi Laura-Mae Baldwin

PURPOSE Although screening with fecal occult blood testing (FOBT) reduces colorectal cancer (CRC) mortality, its effectiveness may diminish if patients do not adhere with repeated screenings. Among patients who had previously engaged in FOBT screening, we assessed subsequent adherence with FOBT screening. METHODS We assessed longitudinal adherence with biennial FOBT screening (every other yea...

Background While colorectal cancer (CRC) is one of the most preventable causes of cancer mortality, it is one of the leading causes of cancer death in Canada where CRC screening uptake is suboptimal. Given the increased rate of mortality and morbidity among mental health patients, their condition could be a potential barrier to CRC screening due to greater difficulties in adhering to behaviours...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید